Discover 715 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 715
Active & Responsive
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
for
Pulmonary Nodule, Solitary, Lung Cancer
Location: Kansas City KS, Kansas City MO, Springfield MO,
Sponsor: Veracyte, Inc.
Sex: All
Age: 29 - 70+
Code: NCT06426628
Recruiting
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Kansas City KS, Liberty MO, Iowa City IA, Tyler TX,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase 2, Recruiting
Active & Responsive
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Location: Kansas City KS, Madison WI, Aurora CO, Denver CO,
Sponsor: Marker Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05798897
Phase 1, Recruiting
Active & Responsive
Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management
for
Breast Cancer Female
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: Female
Age: 65+
Code: NCT07242118
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
for
Pulmonary Arterial Hypertension
Location: Kansas City KS, Omaha NE, Anderson SC, Rochester NY,
Sponsor: Insmed Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07481981
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for
Parkinson Disease
Location: Kansas City KS, Little Rock AR, Indianapolis IN,
Location: Kansas City MO, Wichita KS, Springfield IL, Dallas TX,
Sponsor: ReCor Medical, Inc.
Sex: All
Age: 18+
Code: NCT06297291
Recruiting
Active & Responsive
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block
for
Heart Block Complete, Heart Block Second Degree
Location: Kansas City KS, Minneapolis MN, Milwaukee WI, Denver CO,
Sponsor: The Hospital for Sick Children
Sex: Female
Age: 16 - 50
Code: NCT04559425
Recruiting
Active & Responsive
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
for
AML With Gene Mutations
Location: Lawrence KS, Chicago IL, Dallas TX, Cincinnati OH,
Sponsor: Lomond Therapeutics Holdings, Inc.
Sex: All
Age: 18+
Code: NCT06366789
Phase 1, Recruiting
Active & Responsive
Building Healthy Eating and Self-Esteem Together for University Students
for
Eating Disorders (Excluding Anorexia Nervosa),
Location: Lawrence KS
Sponsor: University of Kansas
Sex: All
Age: 18 - 65
Code: NCT07060534
Recruiting
Active & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for
Obesity, Overweight
Location: Topeka KS, West Des Moines IA, Dallas TX, Tuscaloosa AL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07321886
Phase 3, Recruiting
Active & Responsive
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
for
Overweight, Obesity
Location: Topeka KS, Springfield MO, City of Saint Peters MO,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07589608
Phase 2, Recruiting
Active & Responsive
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
for
Obesity, Overweight
Location: Topeka KS, Springfield MO, West Des Moines IA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06143956
Phase 2, Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Topeka KS, Jefferson City MO, Lincoln NE, Des Moines IA,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Olathe KS, Overland Park KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase 3, Recruiting
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
for
Heart Failure
Location: Olathe KS, Kansas City MO
Sponsor: Saint Luke's Health System
Sex: All
Age: 18 - 70+
Code: NCT05388097
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Olathe KS, Kansas City MO, Lawrence KS, Topeka KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06498635
Phase 3, Recruiting
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Olathe KS, Overland Park KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07391774
Phase 3, Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
for
Malignant Solid Neoplasm
Location: Olathe KS, Overland Park KS, Fairway KS, Westwood KS,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 0+
Code: NCT06295367
Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
for
Locally Advanced Urothelial Carcinoma,
Location: Olathe KS, Overland Park KS, Westwood KS,